← SynDRA
XEVINAPANT
SynDRA canonical compound SYN0033983 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | BIRC2 | BIRC3 | XIAP |
| Mechanism of action | IAP antagonist |
All known targets
- BIRC2
- BIRC3
- XIAP
- XIAP; BIRC2; BIRC3; NAIP; BIRC5; BIRC7
Mechanisms of action (all sources)
- IAP antagonist
- Modulator
- BIRC3 INHIBITOR
- XIAP INHIBITOR
- BIRC2 INHIBITOR
Cross-references
Synonyms
- At-406
- DEBIO-1143
- D-1143
- IAP INHIBITOR AT-406
- MSC2735845A
- SM-406
- AT-406
- SM 406
- (5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
- CHEMBL2158051
- QCR-136
- UNII-N65WC8PXDD
- N65WC8PXDD
- AT406 (SM-406, ARRY-334543)
- J-501625
- (5S,8S,10aR)-N-(Diphenylmethyl)-5-[(N-methyl-L-alanyl)amino]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
- AT-406/Debio-1143
- AT 406
- AT406
- Debio1143
- Debio-1143
- Iap inhibitor AT-406
- D 1143
- RefChem:53402
- SMAC Mimetic Debio 1143
- IAPs Inhibitor Debio 1143
- IAPs Antagonist Debio 1143
- D1143
- AT-406(AT406)
- Xevinapant [INN]
- AT406 (SM-406)
- DeBio-1143 (AT-406)
- MFCD22124467
- C32H43N5O4
- AT-406Xevinapant?
- XEVINAPANT [USAN]
- XEVINAPANT [WHO-DD]
- Xevinapant (JAN/USAN/INN)
- GTPL7729
Look up XEVINAPANT in the interactive SynDRA portal →